5 Key Takeaways

• 1

  Stem cell therapy derived from human exfoliated deciduous teeth (SHED) shows potential for treating children with cerebral palsy.

• 2

  Cerebral palsy affects 2-3 children per 1,000 live births and is caused by early brain injury disrupting movement and posture.

• 3

  SHED cells can be collected noninvasively from naturally shed baby teeth and have regenerative properties.

• 4

  The study found SHED therapy was well tolerated with no serious adverse events, and some participants showed functional improvements.

• 5

  Further research is necessary to confirm the long-term safety and effectiveness of SHED-based therapies in larger trials.